Analysts’ Recent Ratings Updates for Neogen (NEOG)

Several brokerages have updated their recommendations and price targets on shares of Neogen (NASDAQ: NEOG) in the last few weeks:

• 12/15/2025 – Neogen had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/13/2025 – Neogen was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 12/10/2025 – Neogen was upgraded by analysts at CJS Securities from a “market perform” rating to an “outperform” rating. They now have a $10.00 price target on the stock.
• 12/1/2025 – Neogen had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Neogen had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – Neogen had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/9/2025 – Neogen was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/1/2025 – Neogen was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.